ATE435019T1 - Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung - Google Patents

Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung

Info

Publication number
ATE435019T1
ATE435019T1 AT01967534T AT01967534T ATE435019T1 AT E435019 T1 ATE435019 T1 AT E435019T1 AT 01967534 T AT01967534 T AT 01967534T AT 01967534 T AT01967534 T AT 01967534T AT E435019 T1 ATE435019 T1 AT E435019T1
Authority
AT
Austria
Prior art keywords
diuretic
sulfonyl urea
antiviral treatment
treatment
antiviral
Prior art date
Application number
AT01967534T
Other languages
English (en)
Inventor
Ian Stuart Pardoe
Christopher Edward Hartley
Original Assignee
Henderson Morley Res & Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0023199A external-priority patent/GB2367242B/en
Priority claimed from GB0104030A external-priority patent/GB0104030D0/en
Priority claimed from GB0104031A external-priority patent/GB0104031D0/en
Priority claimed from GB0114947A external-priority patent/GB2376628B/en
Application filed by Henderson Morley Res & Dev Ltd filed Critical Henderson Morley Res & Dev Ltd
Application granted granted Critical
Publication of ATE435019T1 publication Critical patent/ATE435019T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01967534T 2000-09-21 2001-09-21 Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung ATE435019T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0023199A GB2367242B (en) 2000-09-21 2000-09-21 Antiviral treatment
GB0104030A GB0104030D0 (en) 2001-02-19 2001-02-19 Antiviral treatment
GB0104031A GB0104031D0 (en) 2001-02-19 2001-02-19 Antiviral treatment
GB0114947A GB2376628B (en) 2001-06-19 2001-06-19 Treatment of DNA viral infections in cats
PCT/GB2001/004206 WO2002024207A1 (en) 2000-09-21 2001-09-21 Diuretic or sulphonylurea for use in antiviral treatment

Publications (1)

Publication Number Publication Date
ATE435019T1 true ATE435019T1 (de) 2009-07-15

Family

ID=27447886

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01967534T ATE435019T1 (de) 2000-09-21 2001-09-21 Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung

Country Status (6)

Country Link
US (1) US20040034016A1 (de)
EP (1) EP1322316B1 (de)
AT (1) ATE435019T1 (de)
AU (1) AU2001287907A1 (de)
DE (1) DE60139134D1 (de)
WO (1) WO2002024207A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE306275T1 (de) * 1999-12-30 2005-10-15 Henderson Morley Res & Dev Ltd Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten
MXPA05008527A (es) 2003-02-12 2006-03-08 Univ Georgetown Uso de artemisinina para tratar tumores inducidos por virus oncogenicos y para tratar infecciones virales.
JP2007504136A (ja) 2003-08-28 2007-03-01 ニトロメッド インコーポレーティッド ニトロソ化およびニトロシル化利尿化合物、組成物、ならびに使用方法
WO2006091716A2 (en) 2005-02-24 2006-08-31 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
GB0517838D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Transdermal active principle delivery means
GB0517840D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Topical anti viral formulations
US10188617B2 (en) 2013-03-12 2019-01-29 The Board Of Trustees Of The Leland Stanford Junior University Modulation of cellular DNA repair activity to intercept malignancy
WO2015148684A2 (en) * 2014-03-26 2015-10-01 Gutierrez Enrique G Compositions and related methods for treating and preventing viral and retroviral infections
US11260074B2 (en) 2014-03-26 2022-03-01 Enrique G. Gutierrez Compositions and related methods for reconstituting the immune system of a subject

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
JPH07179347A (ja) * 1993-12-21 1995-07-18 Showa Shell Sekiyu Kk 抗ウイルス組成物
US5686100A (en) * 1994-11-22 1997-11-11 E.R. Squibb & Sons, Inc. Prophylactic and therapeutic treatment of skin sensitization and irritation
FR2770925B1 (fr) * 1997-11-12 2000-01-07 Sagem Procede de transmission de telecommandes
PT1242119E (pt) * 1999-12-30 2004-08-31 Henderson Morley Res & Dev Ltd Combinacoes para o tratamento de infeccoes por virus adn incluindo um diuretico de ansa e um glicosido cardiotonico
ATE306275T1 (de) * 1999-12-30 2005-10-15 Henderson Morley Res & Dev Ltd Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten

Also Published As

Publication number Publication date
AU2001287907A1 (en) 2002-04-02
US20040034016A1 (en) 2004-02-19
EP1322316B1 (de) 2009-07-01
EP1322316A1 (de) 2003-07-02
DE60139134D1 (de) 2009-08-13
WO2002024207A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
BRPI0411900A (pt) compostos antivirais e métodos
BR0107403A (pt) Compostos de n-(5,7-dimetóxi[1,2,4] triazolo[1,5-alfa]pirimidin-2-il)arilsulfonamida e o uso dos mesmos como herbicidas
DK1265889T3 (da) Lægemidler imod virussygdomme
FI893962A7 (fi) HIV-proteaasi-inhibiittoreita, jotka ovat hyödyllisiä AIDS:in hoidossa
DE69909756D1 (de) Antivirale pyrimidinderivate
IS7556A (is) Uppsöfnun í frumu á phosphomate hliðstæðum a HIV próteasa hindrandi efnasamböndum
DE60317060D1 (de) Mikrobizide pyrimidine oder triazine zur vorbeugung der sexuellen übertragung von hiv
FI906212A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDSin hoidossa
DK0634927T3 (da) Behandling og profylakse af sygdomme forårsaget af parasitter eller bakterier
DE60219292D1 (de) Pyrazolderivate zur behandlung von hiv
ATE418554T1 (de) 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen
ATE249219T1 (de) Antivirale verbindungen
DE60020820D1 (de) Thiadiazolyl-harnstoffe oder -thioharnstoffe zur antiviralen behandlung
DE60100625D1 (de) Verwndung von verbindungen mit 5-ht1a aktivität zur behandlung von krankheiten der äusseren retina
DK1362052T3 (da) Inhibitorer af cruzipain og andre cysteinproteaser
DK1299354T3 (da) Faktor VIIA hæmmende (thio)urea-derivater, fremstilling og anvendelse deraf
DE60139134D1 (de) Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung
DK1242119T3 (da) Kombinationer til behandling af DNA-virale infektioner omfattende et loop-diuretikum og et hjerteglycosid
DE60015568D1 (de) Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür
BR0115121A (pt) Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE502004005245D1 (de) Hohlprofil zum Befestigen von Gegenständen
DE69718911D1 (de) Interleukin - 8 als antivirale- und antitumorwirkstoffe
ATE521640T1 (de) Anti-tsg101-antikörper und ihre verwendungen bei der behandlung von virusinfektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties